Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Candidates for agencies in HHS have been an important part of Trump's Make America Healthy Again agenda, a platform for ...

Scientists in the US who do research on mRNA technology worry their funding may be cut under President Trump. mRNA technology is the basis for COVID- and other vaccines and could play a role in cancer ...

A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.

Rep. Marjorie Taylor Greene calls for yanking FDA approval of COVID-19 vaccines, says that "COVID-19 vaccines are causing ...

Although grants on mRNA-vaccine research have not yet been terminated en masse as they have for other topics — including ...

Thirty minutes was all that former President Joe Biden’s top health officials had allotted to discuss a policy that would ...

Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...

From muddying the waters on vaccine policy to espousing MAHA, Kennedy’s first month in office offers a glimpse into the next four years of public health.

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

Total company revenue fell from a peak of $19.3 billion in 2022 to $3.2 billion for the full year ended Dec. 31, 2024. For ...

U.S. health agency leadership and policymakers seem intent on undermining trust in mRNA, the technology that saved millions of lives during the covid pandemic and has shown promise in addressing a ...